US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28

0.0000

Volume:- -

Turnover:- -

Market Cap:1.60M

PE:- -

High:53.28

Open:53.28

Low:53.28

Close:53.28

52wk High:56.90

52wk Low:48.44

Shares:30.00K

Float Shares:10.00K

Volume Ratio:- -

T/O Rate:- -

Dividend:0.58

Dividend Rate:1.08%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

AstraZeneca Hedges Threat to Oncology Portfolio

Bernstein Remains a Buy on AstraZeneca (AZN)

Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon

Top Premarket Gainers

MT Newswires Live

AstraZeneca Dips Toes in Emerging Class of Cancer Drugs

Hutchmed Lung-Cancer Fighting Drug Submitted to FDA for Approval

MT Newswires Live

AstraZeneca Broadens Oncology Portfolio Through Summit Deal

Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC

Stocks to Watch: Summit Therapeutics, Sangoma, Navitas

Summit Therapeutics, AstraZeneca enter clinical collaboration agreement

AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

AstraZeneca Advances Friday, Outperforms Market

AstraZeneca sBLA for Imfinzi combination accepted, granted Priority Review

AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy

MT Newswires Live

AstraZeneca PLC Stock Falls Thursday, Outperforms Market

AstraZeneca (AZN) Receives a Buy from RBC Capital

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/AZNH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1790798400000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"09-30 18:51:51 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":48.44,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672786357","title":"AstraZeneca PLC Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672786357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672786357?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:01","pubTimestamp":1790784060,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC dropped 0.5% to SEK1,633.50 Wednesday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.4% to 2,597.48.This was the stock's second consecutive day of losses.The company closed SEK292.00 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 340,626, compared to the 50-day average trading volume of 628,478.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443895.HKD","LU0320765992.SGD","LU0889565916.HKD","LU2237443978.SGD","LU0109394709.USD","LU0310800379.SGD","LU1829250122.USD","LU2462157665.USD","AZNH","LU2237443382.USD","LU2468319806.SGD","IE00B3T34201.USD","LU0029864427.USD","LU2456880835.USD","LU1267930573.SGD","BK4568","LU2236285917.USD","LU0289739699.SGD","LU0432979614.USD","BK4585","BK4007","LU2089984988.USD","LU0708994859.HKD","LU0058720904.USD","AZN","LU2237443622.USD","LU2237443549.SGD","LU0128525929.USD","BK4588","LU2417539215.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671272895","title":"AstraZeneca Hedges Threat to Oncology Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2671272895","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671272895?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:44","pubTimestamp":1790757840,"startTime":"0","endTime":"0","summary":"0844 GMT - AstraZeneca is hedging against a key threat to its antibody drug conjugate portfolio through its collaboration with Summit Therapeutics, Citi analysts say in a research note. The agreement has limited immediate impact, but it is a sensible move by the U.K. drugmaker in case medicines like Summit's ivonescimab--known as PD-1/VEGF--become an alternative backbone therapy to existing treatments called PD-1 and PD-L1, the analysts say. AstraZeneca is testing its Datroway antibody drug conjugate in combination with its PD-L1 medicine Imfinzi for lung cancer in a late-stage clinical trial. Moreover, AstraZeneca's stake in Summit gives it exposure to PD-1/VEGF in the event the drug class takes off, the analysts add. AstraZeneca shares rise 0.1%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU2456880835.USD","LU2237443549.SGD","LU2237443895.HKD","BK4007","LU2236285917.USD","LU0432979614.USD","LU2089984988.USD","LU0310800379.SGD","LU2237443978.SGD","LU0109394709.USD","LU0128525929.USD","LU2237443382.USD","LU0708994859.HKD","AZN","LU0058720904.USD","LU2462157665.USD","SMMT","LU2468319806.SGD","BK4585","BK4588","LU2237443465.HKD","IE00B3T34201.USD","BK4568","LU2417539215.USD","AZNH","LU0289739699.SGD","LU0320765992.SGD","LU0889565916.HKD","LU0029864427.USD","LU2237443622.USD","BK4139","LU2488822045.USD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671246350","title":"Bernstein Remains a Buy on AstraZeneca (AZN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671246350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671246350?lang=en_us&edition=fundamental","pubTime":"2026-09-30 00:05","pubTimestamp":1790697924,"startTime":"0","endTime":"0","summary":"In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca, with a price target of p20,200.00. Smith covers the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-astrazeneca-azn-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-buy-on-astrazeneca-azn-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2456880835.USD","LU0029864427.USD","LU0128525929.USD","BK4588","LU0289739699.SGD","LU2468319806.SGD","LU1267930573.SGD","LU0320765992.SGD","LU0889565916.HKD","IE00B3T34201.USD","BK4007","LU1829250122.USD","LU0310800379.SGD","LU2462157665.USD","BK4568","LU2237443465.HKD","LU0432979614.USD","LU2237443382.USD","LU2237443549.SGD","LU0708994859.HKD","AZNH","LU2237443978.SGD","BK4585","LU2236285917.USD","LU2237443622.USD","LU2089984988.USD","LU0058720904.USD","LU0109394709.USD","LU2237443895.HKD","AZN","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119106957","title":"Premarket: Nasdaq Futures Rise 0.45% as Traders Eye Trump AI Luncheon","url":"https://stock-news.laohu8.com/highlight/detail?id=1119106957","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119106957?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:53","pubTimestamp":1790686416,"startTime":"0","endTime":"0","summary":"Tuesday's U.S. stock and Treasury markets lacked clear direction, with traders staying cautious ahead of the week's first labor market data and a series of AI-related events. Oil prices fluctuated....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4608","LU1119994496.HKD","IE00BLSP4452.SGD","LU2168564149.EUR","LU2211815571.USD","LU0472753341.HKD","AIQ","LU2746668461.USD","LU2471134952.CNY","LU2357627491.SGD","SPX","ARTY","GS","LU1366192091.USD","LU2023250843.SGD","BK4007","SGXZ51526630.SGD","LU1244550221.USD","LU0289961442.SGD","LU2237443895.HKD","TECS","BK4614","GSX","LU2461242641.AUD","SAMD0main","IE00BJLML261.HKD","UYG","FTXO","LU0265550946.USD","QDTE","XLF","LU0320765992.SGD","LU2552382132.HKD","IE00BN8TJ469.HKD","LU1989772923.USD","JPO","VFH","LU2168564065.EUR","LU1951200564.SGD","LU2462157665.USD","IE00B64QTZ34.USD","LU1629891620.HKD","CHAT","LU1880398554.USD","IE00BZ1G4Q59.USD","LU2471134879.HKD","LU0289739343.SGD","LU2552382215.SGD","LU0289739699.SGD","LU2089984988.USD","QQQY","LU0265550359.USD","BK4141","TRUF","LU2250418816.HKD","LU0868494617.USD","TTEQ","LU2458330169.SGD","LU1116320901.HKD","IE00BDRTCR15.USD","LU2471134796.USD","IE00BLSP4239.USD","LU0868494708.USD","ILDR","IE00BHPRN162.USD","LU0234572021.USD","IE00BYXW3230.USD","SMHX","LU0742534661.SGD","LU0267386448.USD","SOXY","IE0004091025.USD","NVIW.SI","LU2756315664.SGD","AMDS","LU1244550577.SGD","LU2023250330.USD","LU2237443622.USD","LU0787776722.HKD","LU2417539215.USD","LU2361044949.HKD","AMYY","LU1868836591.USD","LU1145028129.USD","AMDW","LU0210536198.USD","LU0251142724.SGD","LU0348723411.USD","IE000F7OJYX1.SGD","LU1670628061.USD","LU1951198990.SGD","LU0417517546.SGD","LU0820562030.AUD","IE00BK4W5L77.USD","LU2106854487.HKD","GAMR","LU0823434740.USD","LU1868836757.USD","LU0234570918.USD","LU1363072403.SGD","TFNS","LU0353189680.USD","LU0057025933.USD","LU0792757196.USD","LU0889566641.SGD","LU2168564222.USD","LU1989764748.USD","LU2213496289.HKD","TQQY","LU0149725797.USD","LU2488822045.USD","BK4566","LU1267930573.SGD","BK4529","LU2237438978.USD","CNAV","LU2381873111.SGD","LU0211328371.USD","LU0323591593.USD","BK4585","GPIQ","LU2355687059.USD","LU2592432038.USD","IE00BMPRXQ63.HKD","LU2543165471.USD","LU1868836914.USD","LU2089985449.USD","LU1861215975.USD","LU1914381329.SGD","IXG","FTEC","LU0345770308.USD","AMDY","IE00B1XK9C88.USD","IE00BMPRXR70.SGD","LU1852331112.SGD","IE000M9KFDE8.USD","BK4533","LU0274383776.USD","LU1551013425.SGD","QQQM","LU1989764664.SGD","SOXX","IE00BLDYK493.USD","IE00BWXC8680.SGD","LU0310799852.SGD","BK4605","LU0889565916.HKD","BK4209","LU1261432733.SGD","LU0256863902.USD","LU0106261372.USD","LU0823421333.USD","BK4504","LU2552382058.USD","LU2247934214.USD","TRFK","IE00BJTD4V19.USD","LU0109392836.USD","LU1244550494.USD","TEK","LU0208291251.USD","LU0511384066.AUD","LU1116320737.USD","LU0029864427.USD","BK4581","LU0882574139.USD","LU2456880835.USD","IE00BBT3K403.USD","LU0820561909.HKD","LU1232071149.USD","LU1988902786.USD","LU2236285917.USD","LU2430703095.HKD","LU1496350502.SGD","LU0719512351.SGD","LU0069063385.USD","AZNH","IE00BQXX3F31.USD","LU0708994859.HKD","IE0034235303.USD","LU0310800379.SGD","PSI","NVTA","LU0238689110.USD","LU2265009873.SGD","JPM","AMDG","LU2054465674.USD","LU0215105999.USD","BK4575","LU0786609619.USD","TRUMP.USD.CC","IE0004086264.USD","BK4516","LU0942090050.USD","LU1923623000.USD","AMUU","IYF","PSQ","IE0001KFT4U8.USD","BK4573","LU1032466523.USD","LU0820561818.USD","LU0251131958.USD","BK4196","SGXZ81514606.USD",".IXIC","BK4512","LU2237443465.HKD","LU2290526834.HKD","IE000SO60NU8.SGD","IE000WAW04H5.SGD","LU0689472784.USD","QLD","IE0000B7K699.USD","LU0082616367.USD","BK4550","LU0096364046.USD","LU2023250504.SGD","IE00BKVL7J92.USD","AMD","LU0198837287.USD","AMDD","LU0496365809.HKD","AZN","LU1267930730.SGD","LU2237443978.SGD","LU0353189763.USD","BK4207","BK4612","LU1803068979.SGD","LU0211326839.USD","KBWB","KMX","LU0109394709.USD","LU0432979614.USD","IE00BDCRKT87.USD","SAMD02609","JEPQ","BK4023","LU0964807845.USD","LU0823421416.USD","LU2168564495.EUR","LU2168563687.JPY","LU2237443549.SGD","LU0211331839.USD","IYW","QYLG","BK4568","LU0081259029.USD","LU0345769128.USD","LU1316542783.SGD","LU0106831901.USD","LU0056508442.USD","LU2746668974.SGD","LU0256863811.USD","BK4543","LU1084165304.USD","LU1861559042.SGD","SMMT","LU2468319806.SGD","IE0009356076.USD","LU0061475181.USD","LU2756315318.SGD","LU2098885051.SGD","LU2237443382.USD","LU0128525929.USD","QQQE","WUGI","LU1868837300.USD","LU1670627923.USD","FAI","LU1267930490.SGD","CHPS","BK4588","XNTK",".HXC","LU0048584097.USD","LU2462591350.SGD","LU1880398471.USD","FTXL","IE00B1BXHZ80.USD","IE00BQXX3C00.GBP","IE00B5949003.HKD","LU1366333091.USD","ONEQ","LU1791807156.HKD","LU1917777945.USD","LU0070302665.USD","LU1303367103.USD","DAMD","LU2357305700.SGD","LU1894683348.USD","BK4552","BK4547","LU2750360997.AUD","FICO","BK4127","LU2108987350.USD","LU1974910355.USD","LU2430703251.USD","LEGR","IE00BFXG1179.USD","LU1551013342.USD","LU0859254822.USD","LU1804176565.USD","LU2505996509.AUD","LU0127658192.USD","SG9999002232.USD","LU0683600562.USD","MNQmain","LU2505996681.GBP","LU1496350171.SGD","LU0170899867.USD","LU0133085943.USD","LU0640476718.USD","LU1868837136.USD","LU1064131342.USD","IETC","IE00BQXX3D17.EUR","LU0345770993.USD","FNCL","NDX","LU2361044865.SGD","IE000MB6IJN5.SGD","LU0708995401.HKD","AIS","QQQA","LU0971096721.USD","AMDC","LU0048573561.USD","BK4214","LU0187121727.USD","LU0211326755.USD","BK4554","LU0345769631.USD","LU2931357623.SGD","SG9999002224.SGD","LU1720051108.HKD","IE00B19Z3B42.SGD","LU0203345920.USD","USXF","BK4139","LU0390134368.USD","SMH","IE00B3T34201.USD","IE00BK4W5M84.HKD","LU1242518857.USD","LU1267930813.SGD","LU0174119429.USD","LU0320765646.SGD","LU2750360641.GBP","LU2896262040.SGD","SG9999001424.SGD","LU0211327993.USD","LU0157215616.USD","LU1829250122.USD","LU2458330243.SGD","LU2242649171.HKD","AMDL","LU2264538146.SGD","IE0034235188.USD","BK4534","IE00BMPRXN33.USD","LU1280957306.USD","LU1894683264.USD","IE00B19Z3581.USD","BK4532","LU0251132253.USD","SGXZ99366536.SGD","LU0109391861.USD","LU0889565833.HKD","LU0203347892.USD","LU2430703178.SGD","BAI","LU1548497426.USD","LU2361045086.USD","LU0006306889.USD","LU2471134523.USD","DJT","LU2244417387.USD","LU0320765059.SGD","IE00BJTD4N35.SGD","IE0004445239.USD","BK4077","IE0034235295.USD","LU1861558580.USD","IE00B775SV38.USD","LU1242518931.SGD","LU1162221912.USD","LU0976567544.SGD","AMDU","LU1144417596.USD","FDIQ","IE00BSNM7G36.USD","LU1720051017.SGD","IYG","QID","DJTU","IE00B3S45H60.SGD","NQmain","LU0672654240.SGD","IE0002270589.USD","IE00BKDWB100.SGD","LU2860962120.EUR","LU1861220033.SGD","LU2360106780.USD","BLMN","LU2360107168.USD","LU0979878070.USD","QQQJ","LU2087625088.SGD","WISE","LU0642271901.SGD","LU0058720904.USD","LU1668664300.SGD","LU0823434583.USD","LU1989772840.SGD","IE000BZT7R73.USD","LU0943347566.SGD","LU0320765489.SGD","JPMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671169572","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671169572","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671169572?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:12","pubTimestamp":1790680360,"startTime":"0","endTime":"0","summary":"Summit Therapeutics  shares were up more than 23% pre-bell Tuesday after AstraZeneca  agreed to invest $2 billion in convertible preferred shares in Summit, along with a nonbinding clinical collaboration focused on ivonescimab and sonesitatug vedotin.Navitas Semiconductor  stock was 12% higher after the company said late Monday it was awarded the Accelerated, Large-Area, 10 kV SiC IGBT program to develop next-generation 10-kilovolt silicon carbide power semiconductor technology.Q32 Bio  shares were up 9% after Jefferies initiated the company's coverage at buy with a $29 price target.Deep Fission  stock was 8.7% higher, partially reversing the 13% loss at Monday's close.Armada Acquisition Corp. II  shares were up over 8% after a marginal retreat at the prior close.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443622.USD","LU2237443382.USD","XRPN","LU0889565916.HKD","LU2237443895.HKD","LU0432979614.USD","AZNH","FISN","NVTS","LU0320765992.SGD","LU2456880835.USD","QTTB","LU2488822045.USD","LU1829250122.USD","LU0310800379.SGD","BK4141","LU2468319806.SGD","BK4568","LU2462157665.USD","LU0289739699.SGD","BK4105","LU2237443465.HKD","BK4585","LU1267930573.SGD","LU0058720904.USD","BK4588","AZN","BK4139","LU0109394709.USD","IE00B3T34201.USD","BK4007","LU0708994859.HKD","NVTX","LU0128525929.USD","LU2089984988.USD","LU2237443549.SGD","LU0029864427.USD","NVTC","SMMT","LU2417539215.USD","LU2236285917.USD","LU2237443978.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671297054","title":"AstraZeneca Dips Toes in Emerging Class of Cancer Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297054","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671297054?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:15","pubTimestamp":1790673300,"startTime":"0","endTime":"0","summary":"0914 GMT - AstraZeneca's investment in Summit Therapeutics gives the U.K. drugmaker skin in the game of an emerging class of cancer drugs, UBS analysts say in a research note. Miami-based Summit is developing a cancer drug called ivonescimab that blocks two proteins known as PD-1 and VEGF. Evidence is emerging that this drug class might be superior to Merck's blockbuster medicine Keytruda and recent data also point to potential for combinations with antibody-drug conjugates, according to UBS. AstraZeneca has an extensive antibody-drug-conjugate portfolio and the Summit deal allows it to generate data across multiple tumor types, the analysts say. \"If the PD-1/VEGF class does become the new standard of care in various cancers, it will be important to have such combination data,\" they add. AstraZeneca shares rise 1.9%.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2237443622.USD","LU2237443382.USD","LU2417539215.USD","BK4139","AZN","SMMT","LU2089984988.USD","LU0889565916.HKD","LU0320765992.SGD","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","LU2462157665.USD","LU0289739699.SGD","LU0432979614.USD","BK4568","BK4007","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","IE00B3T34201.USD","LU2488822045.USD","LU2237443978.SGD","LU2236285917.USD","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD","AZNH","BK4588","LU2468319806.SGD","LU1829250122.USD","LU0058720904.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671292587","title":"Hutchmed Lung-Cancer Fighting Drug Submitted to FDA for Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2671292587","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671292587?lang=en_us&edition=fundamental","pubTime":"2026-09-29 16:26","pubTimestamp":1790670412,"startTime":"0","endTime":"0","summary":"HUTCHMED said Tuesday that partner AstraZeneca  has submitted a New Drug Application to the US Food and Drug Administration for the lung-cancer fighting drugs Orpathys plus Tagrisso.The drug combination treats metastatic non-small cell lung cancers, the tumors of which have over-expression or amplification of proteins on their surfaces, in patients who had disease progression on or after an epidermal growth factor receptor tyrosine kinase inhibitor therapy, said Hutchmed.The drug combination is an oral, biomarker-directed, chemotherapy-free treatment for non-small cell lung cancers, the validity of which is supported by Saffron, a completed global phase III trial, said Hutchmed.The Saffron trial showed the drug combination demonstrated a statistically significant and clinically meaningful improvement in both progression-free survival and overall survival versus doublet platinum-based chemotherapy in patients who progressed on treatment with Tagrisso alone, said Hutchmed.The Orpathys pl","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCM","LU2417539215.USD","LU2237443622.USD","LU0058720904.USD","LU0029864427.USD","LU2462157665.USD","IE00B3T34201.USD","LU0432979614.USD","LU2237443895.HKD","BK4588","LU2237443465.HKD","LABU","LU0128525929.USD","LU2236285917.USD","LU2468319806.SGD","LU0109394709.USD","BK4531","LU2456880835.USD","AZNH","LU1267930573.SGD","LU2237443549.SGD","BK4585","LU2237443978.SGD","LU2089984988.USD","BK4568","LU0708994859.HKD","LU1829250122.USD","AZN","LU0310800379.SGD","LU0889565916.HKD","LU2237443382.USD","BK4007","LU0320765992.SGD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671529344","title":"AstraZeneca Broadens Oncology Portfolio Through Summit Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2671529344","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671529344?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:49","pubTimestamp":1790660940,"startTime":"0","endTime":"0","summary":"0548 GMT - AstraZeneca's agreement with Summit Therapeutics will help the U.K. drugmaker broaden its immuno-oncology portfolio without going all-in, RBC Capital Markets analysts say in a research note. AstraZeneca is investing $2 billion in the Miami-based biotech and entering into a research collaboration centered on ivonescimab, Summit's experimental cancer drug that blocks two proteins--called PD-1 and VEGF--that help tumors grow and evade the immune system. AstraZeneca's investments in this space lacked a so-called PD-1xVEGF asset like ivonescimab, RBC says. Each company retains its development and commercial rights for their assets, which likely signals AstraZeneca believes its own approaches are superior to PD-1xVEGF, the analysts say. Nevertheless, the deal leaves the door open for a potential expansion with Summit in the future, they add.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0109394709.USD","BK4139","LU2237443622.USD","LU2236285917.USD","BK4585","LU0029864427.USD","LU2237443465.HKD","LU0320765992.SGD","AZNH","IE00B3T34201.USD","BK4568","LU1829250122.USD","LU2237443549.SGD","BK4588","LU0432979614.USD","LU2468319806.SGD","LU2456880835.USD","LU2462157665.USD","LU2488822045.USD","LU0310800379.SGD","LU2089984988.USD","LU2417539215.USD","AZN","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0289739699.SGD","LU2237443382.USD","SMMT","BK4007","LU0889565916.HKD","LU0128525929.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671666512","title":"Hutchmed says AstraZeneca submits NDA for ORPATHYS+TAGRISSO in NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671666512","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671666512?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:06","pubTimestamp":1790640404,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) “announces that AstraZeneca (AZN) has submitted a New Drug Application to the US Food and Drug Administration for ORPATHYS (savoliti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/hutchmed-says-astrazeneca-submits-nda-for-orpathystagrisso-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/hutchmed-says-astrazeneca-submits-nda-for-orpathystagrisso-in-nsclc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0109394709.USD","LU2237443622.USD","LU2236285917.USD","BK4585","LU0029864427.USD","LU2237443465.HKD","LU0320765992.SGD","HCM","AZNH","IE00B3T34201.USD","BK4568","LU1829250122.USD","LU2237443549.SGD","BK4588","LU0432979614.USD","LU2468319806.SGD","LU2456880835.USD","LU2462157665.USD","LU0310800379.SGD","LU2089984988.USD","LU2417539215.USD","AZN","LU2237443978.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0289739699.SGD","LU2237443382.USD","BK4007","BK4531","LU0889565916.HKD","LU0128525929.USD","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671630272","title":"Stocks to Watch: Summit Therapeutics, Sangoma, Navitas","url":"https://stock-news.laohu8.com/highlight/detail?id=2671630272","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671630272?lang=en_us&edition=fundamental","pubTime":"2026-09-29 07:13","pubTimestamp":1790637180,"startTime":"0","endTime":"0","summary":"Summit Therapeutics is getting a $2 billion investment from AstraZeneca. The stock rose 17% to $18.08 in after-hours trading Monday.Sangoma Technologies is set to be acquired by BRC in a deal that values the company at $204 million. Shares climbed 39% to $4.98 after the bell.Navitas Semiconductor got an Army grant to develop semiconductor technology. The stock gained 14% to $13.40.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SANG","BK4585","SMMT","BK4020","LU2237443978.SGD","LU2237443622.USD","BK4588","LU2236285917.USD","LU2237443549.SGD","LU1267930573.SGD","LU1829250122.USD","BK4141","LU2462157665.USD","NVTX","LU0432979614.USD","NVTS","LU2237443382.USD","LU2456880835.USD","IE00B3T34201.USD","LU2237443465.HKD","LU0889565916.HKD","BK4139","LU0320765992.SGD","LU0310800379.SGD","LU0058720904.USD","LU0109394709.USD","LU0128525929.USD","AZN","LU0029864427.USD","NVTC","LU2488822045.USD","BK4568","LU2468319806.SGD","LU0289739699.SGD","LU0708994859.HKD","LU2237443895.HKD","BK4007","AZNH","LU2089984988.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671680942","title":"Summit Therapeutics, AstraZeneca enter clinical collaboration agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2671680942","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671680942?lang=en_us&edition=fundamental","pubTime":"2026-09-29 05:40","pubTimestamp":1790631610,"startTime":"0","endTime":"0","summary":"Summit (SMMT) entered into a clinical collaboration agreement with AstraZeneca (AZN) to evaluate sonesitatug vedotin in combination with ivonescima...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-astrazeneca-enter-clinical-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/summit-therapeutics-astrazeneca-enter-clinical-collaboration-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU0310800379.SGD","LU2456880835.USD","LU0029864427.USD","LU0109394709.USD","LU1829250122.USD","LU2462157665.USD","SMMT","LU2468319806.SGD","LU0320765992.SGD","LU2236285917.USD","LU0058720904.USD","LU0289739699.SGD","BK4539","LU1267930573.SGD","LU2237443895.HKD","LU2237443382.USD","LU2237443622.USD","LU2237443465.HKD","BK4568","IE00B3T34201.USD","LU2488822045.USD","AZNH","BK4007","BK4139","LU0128525929.USD","BK4585","AZN","LENZ","LU2237443549.SGD","BK4588","LU2417539215.USD","LU2089984988.USD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671251560","title":"AstraZeneca Advances Fixed-Dose Cholesterol Combo With Completed Phase I Bioavailability Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671251560","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671251560?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:30","pubTimestamp":1790613011,"startTime":"0","endTime":"0","summary":"AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca (AZN) has completed a Phase I study titled “A Phase I, R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-fixed-dose-cholesterol-combo-with-completed-phase-i-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/astrazeneca-advances-fixed-dose-cholesterol-combo-with-completed-phase-i-bioavailability-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2237443622.USD","LU2237443382.USD","LU2417539215.USD","AZN","LU2089984988.USD","LU0889565916.HKD","LU0320765992.SGD","LU0029864427.USD","LU0310800379.SGD","LU0128525929.USD","LU2462157665.USD","LU0289739699.SGD","LU0432979614.USD","BK4568","BK4007","LU0708994859.HKD","LU2237443549.SGD","LU2237443895.HKD","IE00B3T34201.USD","LU2237443978.SGD","LU2236285917.USD","LU2237443465.HKD","LU1267930573.SGD","LU0109394709.USD","AZNH","BK4588","LU2468319806.SGD","LU1829250122.USD","LU0058720904.USD","LU2456880835.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671596092","title":"AstraZeneca PLC Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2671596092","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671596092?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:01","pubTimestamp":1790611260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC rose 0.6% to SEK1,650.50 Monday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 0.6% to 2,608.33.This was the stock's second consecutive day of gains.The company closed SEK275.00 below its 52-week high of SEK1,925.50, which the company reached on April 10, 2026.Trading volume was 535,612, compared to the 50-day average trading volume of 615,757.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"nz","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU1057294990.SGD","AZN","BK4588","AZNH","BK4581","LU2112291526.USD","IE00B4R5TH58.HKD","LU2237443622.USD","PJP","LU0109394709.USD","LU0128525929.USD","BIB","LU2089984988.USD","IE00BJT1NW94.SGD","LU0708994859.HKD","TBXU","BK4566","LU1829250122.USD","LU2237443978.SGD","LU0320765992.SGD","BK4533","IE0009355771.USD","LU1571399168.USD","LU2237443465.HKD","LU2237443895.HKD","LU0889565916.HKD","LU0432979614.USD","LU2242652126.USD","AMGN","IBB","IE0002141913.USD","LU0310800379.SGD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2468319806.SGD","BBH","BK4007","LU2237443382.USD","BK4534","LU0289739699.SGD","LU0122379950.USD","IE00B3T34201.USD","LU0058720904.USD","LU2236285917.USD","IBBQ","PBE","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670242653","title":"AstraZeneca Advances Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670242653","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670242653?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:09","pubTimestamp":1790352540,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.AstraZeneca PLC  shares rallied 1.23% to GBP125.52 Friday, on what proved to be an all-around positive ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","LU2456880835.USD","LU2468319806.SGD","LU1829250122.USD","LU0029864427.USD","BK4585","LU0310800379.SGD","LU2237443622.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0708994859.HKD","LU0128525929.USD","LU2237443895.HKD","LU2236285917.USD","BK4007","LU1267930573.SGD","BK4568","AZN","LU2237443978.SGD","LU2237443549.SGD","LU2237443382.USD","AZNH","LU0320765992.SGD","BK4588","LU2417539215.USD","LU0289739699.SGD","LU2089984988.USD","LU0432979614.USD","LU2237443465.HKD","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670448074","title":"AstraZeneca sBLA for Imfinzi combination accepted, granted Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2670448074","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670448074?lang=en_us&edition=fundamental","pubTime":"2026-09-25 18:00","pubTimestamp":1790330414,"startTime":"0","endTime":"0","summary":"AstraZeneca’s (AZN) supplemental Biologics License Application, or sBLA, for Imfinzi in combination with enfortumab vedotin has been accepted by th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/astrazeneca-sbla-for-imfinzi-combination-accepted-granted-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/astrazeneca-sbla-for-imfinzi-combination-accepted-granted-priority-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZN","LU0320765992.SGD","BK4568","LU0109394709.USD","LU0889565916.HKD","LU2237443895.HKD","LU0128525929.USD","BK4007","LU2236285917.USD","LU0029864427.USD","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","LU2237443465.HKD","LU2237443549.SGD","AZNH","BK4588","LU2237443978.SGD","LU0310800379.SGD","LU0289739699.SGD","LU2417539215.USD","LU2456880835.USD","LU2237443622.USD","LU0432979614.USD","BK4585","LU1829250122.USD","LU2462157665.USD","LU2237443382.USD","IE00B3T34201.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445225","title":"AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445225","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445225?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:48","pubTimestamp":1790322524,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Friday the US Food and Drug Administration granted priority review to its application for an Imfinzi combination therapy to treat muscle-invasive bladder cancer.The treatment is intended for patients who cannot or choose not to receive cisplatin-based chemotherapy.The submission is based on a phase 3 trial, which showed the perioperative therapy delivered event-free and overall survival improvements compared with bladder removal surgery with or without approved secondary treatments, the company said.AstraZeneca said the FDA is expected to make a regulatory decision in Q4.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZNH","LU0889565916.HKD","BK4568","LU2468319806.SGD","LU2236285917.USD","LU0029864427.USD","LU2456880835.USD","LU2089984988.USD","AZN","LU1829250122.USD","LU2237443978.SGD","BK4588","LU2237443382.USD","LU0320765992.SGD","LU2237443622.USD","BK4585","LU0432979614.USD","LU2237443549.SGD","LU0109394709.USD","LU0128525929.USD","LU0708994859.HKD","LU2237443465.HKD","LU0310800379.SGD","BK4007","LU0058720904.USD","LABU","LU0289739699.SGD","LU2237443895.HKD","LU1267930573.SGD","IE00B3T34201.USD","LU2462157665.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670494719","title":"AstraZeneca PLC Stock Falls Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2670494719","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670494719?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:01","pubTimestamp":1790265660,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC shed 0.6% to SEK1,630.00 Thursday on what proved to be an overall poor trading session for the stock market, with the OMX Nordic 40 Index falling 1.3% to 2,614.61.This was the stock's second consecutive day of losses.The company closed SEK295.50 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 353,792, compared to the 50-day average trading volume of 611,665.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669458422","title":"AstraZeneca (AZN) Receives a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669458422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669458422?lang=en_us&edition=fundamental","pubTime":"2026-09-24 09:46","pubTimestamp":1790214385,"startTime":"0","endTime":"0","summary":"In a report released on September 21, Trung Huynh from RBC Capital maintained a Buy rating on AstraZeneca, with a price target of p14,500.00. The c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","BK4207","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948722","title":"AstraZeneca PLC Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948722?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:00","pubTimestamp":1790179200,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of AstraZeneca PLC slipped 1.6% to SEK1,639.50 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.8% to 2,648.31.The stock's fall  snapped a four-day winning streak.The company closed SEK286.00 short of its 52-week high of SEK1,925.50, which the company achieved on April 10, 2026.Trading volume was 368,047, compared to the 50-day average trading volume of 614,395.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU0708994859.HKD","LU0128525929.USD","LU0109394709.USD","IE00B3T34201.USD","LU2237443382.USD","LU2417539215.USD","LU1829250122.USD","LU2089984988.USD","AZNH","BK4588","LU2236285917.USD","LU0320765992.SGD","LU2237443895.HKD","LU2237443465.HKD","LU2468319806.SGD","BK4007","LU2237443549.SGD","LU0432979614.USD","LU0289739699.SGD","LU1267930573.SGD","BK4568","BK4585","LU2462157665.USD","LU0889565916.HKD","LU2237443978.SGD","LU0310800379.SGD","LU0029864427.USD","LU2456880835.USD","AZN","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}